Dapagliflozin preferentially reduces fibrosis biomarkers in chronic heart failure patients with high extracellular matrix remodeling activity
10 May 2026 (13:38 - 14:55)
Organised by: 

Abstract
Slides
About the speaker

Biomedical Research Institute of Murcia (IMIB-Arrixaca), El Palmar, Murcia (Spain)
6 More presentations in this session
Doctor M. Badan (Chisinau, MD)
Access the full session
The Event
Heart Failure 2026
10 May 2026
13:38 CET
You may be interested in
Congress Presentation
Congress Session

